PubMed HealthSearch

PubMed · 3355326

Proficiency testing programs--promises, progress, and problems. A 40-year prospective.

Abstract

Proficiency testing as a means of interlaboratory improvement is over 40 years old. Proficiency testing as a tool of the regulatory process is nearly 20. While successful, ie, the quality of laboratory work in the United States has improved significantly during the past 40 years, this union of regulation and education continues to be a marriage of unequals. Clearly, those who started the professional laboratory community on the road to interlaboratory proficiency testing envisioned a promise of improved quality. The promise is fulfilled; even on an interlaboratory basis, the quality of work (precision) approaches or even exceeds the clinicians' requirements for medically useful data. Major problems continue to exist: the prospect of regulating a vast population of "physicians' office laboratories" presents new challenges for program providers, and as methodologies in laboratories have improved, some of the long-held systems of grading and performance evaluation are beginning to fail. The failure is not one of intent, logistics, or statistics. Proficiency testing, as a fine sharp tool, is corrupted when applied in a situation in which it is ill suited to perform. New knowledge will renew the promise and allow the professional, clinical laboratory community to progress.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R H Laessig, S S Ehrmeyer. 1988. Proficiency testing programs--promises, progress, and problems. A 40-year prospective.. https://pubmed.ncbi.nlm.nih.gov/3355326/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas.

OBJECTIVE: To determine the effectiveness of follow-up tests for signaling recurrences in patients with intermediate- and high-risk malignant melanomas treated with curative intention. DESIGN: Retrospective analysis of prospectively collected data. SETTING: North Central Cancer Treatment Group. PATIENTS: A total of 261 patients with resected local (> or = 1.69 mm) and regional nodal malignant melanomas who were enrolled in a single prospective adjuvant trial were studied. All patients were scheduled to be followed up monthly for 2 months, then every 2 months for the first year, every 4 months the second year, every 6 months the next 3 years, and annually thereafter, with each visit consisting of a history, physical examination, complete blood cell count, blood chemistry panel, and a chest x-ray. RESULTS: Of the 145 evaluable patients who developed recurrent melanomas, 99 patients (68%) developed symptoms that signaled the diagnosis of recurrent disease. Physical examination of asymptomatic patients led to the diagnosis of recurrent disease in 37 patients (26%). The other nine patients (6%) with recurrent disease had abnormal chest x-rays. Laboratory results were never a sole indicator of recurrent disease. CONCLUSION: The majority of recurrences following resection of primary melanomas are discovered by history and/or physical examination despite the frequent use of other follow-up tests. The present data indicate that routine blood analyses and chest x-rays have limited value in the postoperative follow-up of patients with resected intermediate- and high-risk melanomas.

Clinical Laboratory Techniques